Clinical Trial

MEDBRIDGE-Guided NCM/CHW Post-Discharge Support for High-Risk T2D Patients

Study acronym: MEDBRIDGE
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This study tests whether a support program led by a nurse case manager and community health worker can help patients with type 2 diabetes manage their medications after leaving the hospital. Many patients with diabetes take multiple medications, and changes to these medications during hospital stays can cause confusion and lead to missed doses or incorrect use. This is especially common in communities with limited access to healthcare. The study uses a computer-based tool called MEDBRIDGE (MEDication BRIDGE) to identify patients who may be at higher risk for problems after discharge, such as worsening blood sugar control or return visits to the emergency department. Patients identified as high-risk will receive 3 months of support from a nurse case manager and community health worker team, who will help with medication questions, coordinate with their doctor, and provide follow-up check-ins. The main goal is to find out whether this type of support program is practical to deliver and acceptable to patients. The study will also track changes in blood sugar levels and emergency department visits. Forty-five patients will be enrolled over 6 months at the University of Alabama at Birmingham and Cooper Green Mercy Health Services in Jefferson County, Alabama.
Trial Details
NCT Number NCT07599852
Lead Sponsor University of Alabama at Birmingham
Conditions Type 2 Diabetes, Medication Adherence, Care Transition, Medication Discrepancy
Enrollment 45 participants
Start Date 2029-05-01
Primary Completion 2030-04-30 (estimated)
Study Completion 2031-04-30 (estimated)
Updated on ClinicalTrials.gov 2026-05-20